Pfizer Oncology Patient Centricity Ecosystem: From Launch to Impact
Patient centricity within Pfizer Oncology is a longstanding tradition, with robust and mature patient advocacy efforts and relationships. In 2019, to expand these efforts and further embed patient insights and experiences into all activities, Pfizer Oncology launched an initiative to create a Patient Centric Ecosystem (POPCE).
Pfizer Oncology Collaborating to Improve Patient Centricity in Clinical Trials
Patient centricity within Pfizer Oncology is a longstanding tradition, with robust and mature patient advocacy efforts and relationships.
Are You Making the Most of Patient Centricity?
Healthcare opportunities are only useful to you if you know they exist and how they work. This downloadable eBook is designed to help you make informed healthcare decisions.
Reimagining diversity in multiple myeloma clinical trials
An article in Hematological Oncology on ways to reimagine diversity in multiple myeloma clinical trials – starting with design led with equity front of mind.
Age: Addressing a Blind Spot in Cancer Care
An article about how Pfizer is addressing disparities in cancer care and improving health equity.
Some Older People Living with Cancer Aim for Remission but Lack Needed Resources to Help Make Treatment Decisions
A global survey report conducted by Pfizer to better understand older people and their caregivers unique experiences and provide a more complete picture of the opportunities to reduce barriers to care.
How Clinical Trials Help Advance Medicine
An article on how clinical trials help advance medicine
The Role of Cyclin-Dependent Kinases (CDK) 2/4/6 in Normal and Tumor Cells
by Sandra T. Asanin, Clinical Research